|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1993-8-10
|
|
pubmed:abstractText |
Carmustine is a chemotherapeutic agent frequently employed in the treatment of malignant brain tumors. The side effect of pulmonary fibrosis occurs in 20 to 30 percent of patients receiving this drug. Herein we report a case of presumed carmustine-induced pulmonary fibrosis occurring with an unusual lobar distribution.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0012-3692
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
104
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
315-7
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
Carmustine toxicity presenting as a lobar infiltrate.
|
|
pubmed:affiliation |
St. Vincent Hospital, Indianapolis.
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
